2020, the ultimate test of business flexibility

Companies have increasingly pivoted from their original business models to address the challenges posed by COVID-19, with many adopting advanced high-performance computing (HPC) solutions to facilitate such transitions. Manufacturers like Tesla and Apple have shifted production to essential medical supplies, while non-healthcare companies have leveraged their expertise in areas such as aerospace and automotive to produce ventilators and personal protective equipment. The adoption of flexible, heterogeneous HPC architectures has played a crucial role, enabling rapid adaptation and deployment of resources to new engineering challenges. Rescale, a cloud-based HPC platform, exemplifies this flexibility by providing diverse computing infrastructures and automating the selection and deployment processes for R&D needs across industries, including biotechnology, pharmaceuticals, and medical devices. This has led to faster innovation cycles, with simulation and modeling increasingly accepted as part of the regulatory approval process. Rescale’s involvement in initiatives like the Tech Against Covid Consortium underscores its commitment to facilitating research and innovation, not only in medical fields but also in areas such as autonomous vehicle safety and storm prediction.